Egypt: Researchers have found in a new study that POCUS demonstrates high sensitivity, specificity, and overall diagnostic accuracy for identifying causes of dyspnea in emergency settings. It ...
Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide and ...
The man's family later sued OptumRx and Walgreens, claiming they didn't offer alternatives after his regular inhaler's price increased dramatically.
Intrapleural enzyme therapy (IET) improves outcomes in adult inpatients with complicated parapneumonic pleural effusion or empyema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results